JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3826
Trupanion
TRUP
$1.03B
| $1.61M | ﹤0.01% |
52,632
-81,285
| -61% | -$2.15M |
2017 Q3
25 quarters
|
|
3827
N-able
NABL
$799M
| $1.61M | ﹤0.01% |
121,160
+7,513
| +7% | +$95.3K |
2021 Q3
9 quarters
|
|
|
NVRO
3828
DELISTED
NEVRO CORP.
NVRO
| $1.6M | ﹤0.01% |
74,579
-43,527
| -37% | -$777K |
2014 Q4
36 quarters
|
|
3829
Janus Henderson Short Duration Income ETF
VNLA
$3.44B
| $1.6M | ﹤0.01% |
33,205
+29,013
| +692% | +$1.39M |
2023 Q1
3 quarters
|
|
3830
Arhaus
ARHS
$1.45B
| $1.6M | ﹤0.01% |
134,600
-63,379
| -32% | -$597K |
2023 Q1
3 quarters
|
|
3831
CALL
Colgate-Palmolive
CL
$67.2B
| $1.59M | ﹤0.01% |
20,000
| – | – |
2021 Q4
8 quarters
|
|
3832
Hudbay
HBM
$12.1B
| $1.59M | ﹤0.01% |
288,801
-49,550
| -15% | -$232K |
2021 Q1
11 quarters
|
|
|
TGI
3833
DELISTED
Triumph Group
TGI
| $1.59M | ﹤0.01% |
96,082
-131,595
| -58% | -$1.33M |
2013 Q2
42 quarters
|
|
|
EVBG
3834
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.59M | ﹤0.01% |
65,514
-90,833
| -58% | -$1.96M |
2017 Q3
25 quarters
|
|
3835
Vanguard ESG International Stock ETF
VSGX
$6.69B
| $1.59M | ﹤0.01% |
28,687
+15,598
| +119% | +$806K |
2022 Q4
4 quarters
|
|
3836
Zillow
ZG
$6.32B
| $1.58M | ﹤0.01% |
27,862
+15,809
| +131% | +$677K |
2020 Q1
15 quarters
|
|
3837
F&G Annuities & Life
FG
$2.87B
| $1.58M | ﹤0.01% |
34,343
-6,411
| -16% | -$239K |
2022 Q4
4 quarters
|
|
3838
PUT
Chemours
CC
$2.06B
| $1.58M | ﹤0.01% |
50,000
| – | – |
2023 Q3
1 quarter
|
|
3839
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.15B
| $1.57M | ﹤0.01% |
66,203
-126,206
| -66% | -$2.76M |
2022 Q1
7 quarters
|
|
3840
Schwab Fundamental International Large Company Index ETF
FNDF
$25.5B
| $1.57M | ﹤0.01% |
46,653
+18,180
| +64% | +$583K |
2018 Q1
23 quarters
|
|
3841
HealthStream
HSTM
$943M
| $1.57M | ﹤0.01% |
58,154
+9,821
| +20% | +$244K |
2017 Q3
25 quarters
|
|
3842
Fidelity Corporate Bond ETF
FCOR
$344M
| $1.57M | ﹤0.01% |
33,399
+4,913
| +17% | +$219K |
2023 Q3
1 quarter
|
|
|
ARIS
3843
DELISTED
Aris Water Solutions
ARIS
| $1.57M | ﹤0.01% |
186,871
-89,600
| -32% | -$770K |
2021 Q4
8 quarters
|
|
3844
OneSpaWorld
OSW
$2.4B
| $1.57M | ﹤0.01% |
111,147
+4,608
| +4% | +$53.6K |
2019 Q2
18 quarters
|
|
|
ML
3845
DELISTED
MoneyLion Inc.
ML
| $1.56M | ﹤0.01% |
24,899
+24,890
| +276,556% | +$837K |
2021 Q4
8 quarters
|
|
3846
CALL
General Dynamics
GD
$89.3B
| $1.56M | ﹤0.01% |
6,000
| – | – |
2022 Q2
6 quarters
|
|
3847
Compass Minerals
CMP
$932M
| $1.56M | ﹤0.01% |
61,487
-10,017
| -14% | -$256K |
2015 Q4
32 quarters
|
|
3848
Matthews International
MATW
$602M
| $1.56M | ﹤0.01% |
42,448
-6,572
| -13% | -$241K |
2013 Q2
42 quarters
|
|
3849
PUT
Viatris
VTRS
$20.2B
| $1.56M | ﹤0.01% |
143,600
-78,400
| -35% | -$751K |
2021 Q4
8 quarters
|
|
3850
Pliant Therapeutics
PLRX
$63.8M
| $1.55M | ﹤0.01% |
85,593
+3,747
| +5% | +$57K |
2020 Q3
13 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.